{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:41:27Z","timestamp":1794336087455,"version":"4.9.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Excessive release of neutrophil extracellular traps (NETs) is associated with disease severity and contributes to tissue injury, followed by severe organ damage. Pharmacological or genetic inhibition of NET release reduces pathology in multiple inflammatory disease models, indicating that NETs are potential therapeutic targets. Here, we demonstrate using a preclinical basket approach that our therapeutic anti-citrullinated protein antibody (tACPA) has broad therapeutic potential. Treatment with tACPA prevents disease symptoms in various mouse models with plausible NET-mediated pathology, including inflammatory arthritis (IA), pulmonary fibrosis, inflammatory bowel disease and sepsis. We show that citrulline residues in the N-termini of histones 2A and 4 are specific targets for therapeutic intervention, whereas antibodies against other N-terminal post-translational histone modifications have no therapeutic effects. Because citrullinated histones are generated during NET release, we investigated the ability of tACPA to inhibit NET formation. tACPA suppressed NET release from human neutrophils triggered with physiologically relevant human disease-related stimuli. Moreover, tACPA diminished NET release and potentially initiated NET uptake by macrophages in vivo, which was associated with reduced tissue damage in the joints of a chronic arthritis mouse model of IA. To our knowledge, we are the first to describe an antibody with NET-inhibiting properties and thereby propose tACPA as a drug candidate for NET-mediated inflammatory diseases, as it eliminates the noxious triggers that lead to continued inflammation and tissue damage in a multidimensional manner.<\/jats:p>","DOI":"10.1038\/s41423-020-0381-3","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T08:03:39Z","timestamp":1584691419000},"page":"1528-1544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4546-1559","authenticated-orcid":false,"given":"Renato G. S.","family":"Chirivi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. G.","family":"van Rosmalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-4151","authenticated-orcid":false,"given":"Maarten","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilien","family":"Euler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonny","family":"Schmets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Bogatkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kambas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinte","family":"Braster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Soehnlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-9922","authenticated-orcid":false,"given":"Markus H.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmuth H. G. van","family":"Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos M. H.","family":"Raats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"381_CR1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"381_CR2","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"key":"381_CR3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.chom.2012.06.011","volume":"12","author":"B McDonald","year":"2012","unstructured":"McDonald, B., Urrutia, R., Yipp, B. G., Jenne, C. N. & Kubes, P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12, 324\u2013333 (2012).","journal-title":"Cell Host Microbe"},{"key":"381_CR4","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2009-05-221606","volume":"114","author":"M Bianchi","year":"2009","unstructured":"Bianchi, M. et al. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114, 2619\u20132622 (2009).","journal-title":"Blood"},{"key":"381_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","volume":"14","author":"F Apel","year":"2018","unstructured":"Apel, F., Zychlinsky, A. & Kenny, E. F. The role of neutrophil extracellular traps in rheumatic diseases. Nat. Rev. Rheumatol. 14, 467\u2013475 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"381_CR6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000489829","volume":"10","author":"V Brinkmann","year":"2018","unstructured":"Brinkmann, V. Neutrophil extracellular traps in the second decade. J. Innate Immun. 10, 414\u2013421 (2018).","journal-title":"J. Innate Immun."},{"key":"381_CR7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.devcel.2018.01.019","volume":"44","author":"G Sollberger","year":"2018","unstructured":"Sollberger, G., Tilley, D. O. & Zychlinsky, A. Neutrophil extracellular traps: the biology of chromatin externalization. Dev. Cell. 44, 542\u2013553 (2018).","journal-title":"Dev. Cell."},{"key":"381_CR8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrgastro.2017.183","volume":"15","author":"M Honda","year":"2018","unstructured":"Honda, M. & Kubes, P. Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system. Nat. Rev. Gastroenterol. Hepatol. 15, 206\u2013221 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"381_CR9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"381_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1189\/jlb.0910538","volume":"89","author":"GB Segel","year":"2011","unstructured":"Segel, G. B., Halterman, M. W. & Lichtman, M. A. The paradox of the neutrophil\u2019s role in tissue injury. J. Leukoc. Biol. 89, 359\u2013372 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"381_CR11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","volume":"21","author":"SL Wong","year":"2015","unstructured":"Wong, S. L. et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat. Med. 21, 815\u2013819 (2015).","journal-title":"Nat. Med."},{"key":"381_CR12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.aam8897","volume":"358","author":"M Jimenez-Alcazar","year":"2017","unstructured":"Jimenez-Alcazar, M. et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science 358, 1202\u20131206 (2017).","journal-title":"Science"},{"key":"381_CR13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","volume":"74","author":"C Carmona-Rivera","year":"2015","unstructured":"Carmona-Rivera, C., Zhao, W., Yalavarthi, S. & Kaplan, M. J. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann. Rheum. Dis. 74, 1417\u20131424 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"381_CR14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","volume":"187","author":"E Villanueva","year":"2011","unstructured":"Villanueva, E. et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187, 538\u2013552 (2011).","journal-title":"J. Immunol."},{"key":"381_CR15","doi-asserted-by":"crossref","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","volume":"114","author":"A Schreiber","year":"2017","unstructured":"Schreiber, A. et al. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc. Natl Acad. Sci. USA 114, E9618\u2013E9625 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"381_CR16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","volume":"15","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15, 1318\u20131321 (2009).","journal-title":"Nat. Med."},{"key":"381_CR17","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur, R. et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5, 178ra40 (2013).","journal-title":"Sci. Transl. Med."},{"key":"381_CR18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623\u2013625 (2009).","journal-title":"Nat. Med."},{"key":"381_CR19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/rheumatology\/key067","volume":"57","author":"M van der Linden","year":"2018","unstructured":"van der Linden, M. et al. Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome. Rheumatol. (Oxf.) 57, 1228\u20131234 (2018).","journal-title":"Rheumatol. (Oxf.)"},{"key":"381_CR20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2011.132","volume":"7","author":"MJ Kaplan","year":"2011","unstructured":"Kaplan, M. J. Neutrophils in the pathogenesis and manifestations of SLE. Nat. Rev. Rheumatol. 7, 691\u2013699 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"381_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","volume":"184","author":"Y Wang","year":"2009","unstructured":"Wang, Y. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184, 205\u2013213 (2009).","journal-title":"J. Cell Biol."},{"key":"381_CR22","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3389\/fimmu.2018.01680","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Myeloid-specific deletion of peptidylarginine deiminase 4 mitigates atherosclerosis. Front Immunol. 9, 1680 (2018).","journal-title":"Front Immunol."},{"key":"381_CR23","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-016-1055-2","volume":"17","author":"A Suzuki","year":"2016","unstructured":"Suzuki, A. et al. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice. BMC Musculoskelet. Disord. 17, 205 (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"381_CR24","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1172\/JCI67390","volume":"123","author":"JS Knight","year":"2013","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Invest 123, 2981\u20132993 (2013).","journal-title":"J. Clin. Invest"},{"key":"381_CR25","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","volume":"74","author":"JS Knight","year":"2015","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice. Ann. Rheum. Dis. 74, 2199\u20132206 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"381_CR26","first-page":"1","volume":"6","author":"RGS Chirivi","year":"2013","unstructured":"Chirivi, R. G. S., Jenniskens, G. J. & Raats, J. M. H. Anti-citrullinated protein antibodies as novel therapeutic drugs in rheumatoid arthritis. J. Clin. Cell Immunol. 6, 1\u201313 (2013).","journal-title":"J. Clin. Cell Immunol."},{"key":"381_CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/protein\/gzw040","volume":"29","author":"T Schlothauer","year":"2016","unstructured":"Schlothauer, T. et al. Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. Protein Eng. Des. Sel. 29, 457\u2013466 (2016).","journal-title":"Protein Eng. Des. Sel."},{"key":"381_CR28","doi-asserted-by":"crossref","unstructured":"Tam, S. H. et al. Functional, biophysical, and structural characterization of human IgG1 and IgG4 Fc variants with ablated immune functionality. Antibodies 6, 12 (2017).","DOI":"10.3390\/antib6030012"},{"key":"381_CR29","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1074\/jbc.M116.748525","volume":"292","author":"FW Jacobsen","year":"2017","unstructured":"Jacobsen, F. W. et al. Engineering an IgG scaffold lacking effector function with optimized developability. J. Biol. Chem. 292, 1865\u20131875 (2017).","journal-title":"J. Biol. Chem."},{"key":"381_CR30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/mi.2012.24","volume":"5","author":"BM Fournier","year":"2012","unstructured":"Fournier, B. M. & Parkos, C. A. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 5, 354\u2013366 (2012).","journal-title":"Mucosal Immunol."},{"key":"381_CR31","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.1701643","volume":"200","author":"I Angelidou","year":"2018","unstructured":"Angelidou, I. et al. REDD1\/autophagy pathway is associated with neutrophil-driven IL-1beta inflammatory response in active ulcerative colitis. J. Immunol. 200, 3950\u20133961 (2018).","journal-title":"J. Immunol."},{"key":"381_CR32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","volume":"368","author":"KA Brown","year":"2006","unstructured":"Brown, K. A. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157\u2013169 (2006).","journal-title":"Lancet"},{"key":"381_CR33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000448808","volume":"9","author":"BM Biron","year":"2017","unstructured":"Biron, B. M. et al. Cl-amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model. J. Innate Immun. 9, 22\u201332 (2017).","journal-title":"J. Innate Immun."},{"key":"381_CR34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12931-016-0472-y","volume":"17","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Pulmonary endothelial activation caused by extracellular histones contributes to neutrophil activation in acute respiratory distress syndrome. Respir. Res. 17, 155 (2016).","journal-title":"Respir. Res."},{"key":"381_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/BOR.0000000000000450","volume":"30","author":"D Soderberg","year":"2018","unstructured":"Soderberg, D. & Segelmark, M. Neutrophil extracellular traps in vasculitis, friend or foe? Curr. Opin. Rheumatol. 30, 16\u201323 (2018).","journal-title":"Curr. Opin. Rheumatol."},{"key":"381_CR36","doi-asserted-by":"crossref","unstructured":"Kienhofer, D. et al. Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight. 2, e92920\u00a0(2017).","DOI":"10.1172\/jci.insight.92920"},{"key":"381_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13075-018-1574-3","volume":"20","author":"RM Ten Brinck","year":"2018","unstructured":"Ten Brinck, R. M., Toes, R. E. M. & van der Helm-van Mil, A. H. M. Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia. Arthritis Res. Ther. 20, 89 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"381_CR38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","volume":"66","author":"J Sokolove","year":"2014","unstructured":"Sokolove, J. et al. Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol. 66, 813\u2013821 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"381_CR39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","volume":"116","author":"KA Kuhn","year":"2006","unstructured":"Kuhn, K. A. et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116, 961\u2013973 (2006).","journal-title":"J. Clin. Invest."},{"key":"381_CR40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20072051","volume":"205","author":"JA Hill","year":"2008","unstructured":"Hill, J. A. et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J. Exp. Med. 205, 967\u2013979 (2008).","journal-title":"J. Exp. Med."},{"key":"381_CR41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.20081862","volume":"206","author":"H Uysal","year":"2009","unstructured":"Uysal, H. et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J. Exp. Med. 206, 449\u2013462 (2009).","journal-title":"J. Exp. Med."},{"key":"381_CR42","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH van der Helm-van Mil","year":"2005","unstructured":"van der Helm-van Mil, A. H., Verpoort, K. N., Breedveld, F. C., Toes, R. E. & Huizinga, T. W. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res. Ther. 7, R949\u2013R958 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"381_CR43","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","volume":"63","author":"LA van de Stadt","year":"2011","unstructured":"van de Stadt, L. A. et al. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum. 63, 3226\u20133233 (2011).","journal-title":"Arthritis Rheum."},{"key":"381_CR44","first-page":"1696","volume":"30","author":"JM Raats","year":"2003","unstructured":"Raats, J. M., Wijnen, E. M., Pruijn, G. J., van den Hoogen, F. H. & van Venrooij, W. J. Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. J. Rheumatol. 30, 1696\u20131711 (2003).","journal-title":"J. Rheumatol."},{"key":"381_CR45","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40920","volume":"71","author":"L Hafkenscheid","year":"2019","unstructured":"Hafkenscheid, L. et al. N-linked glycans in the variable domain of ACPA-IgG predict the development of rheumatoid arthritis. Arthritis Rheumatol. 71, 1626\u20131633 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"381_CR46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrrheum.2017.146","volume":"13","author":"M Seeling","year":"2017","unstructured":"Seeling, M., Bruckner, C. & Nimmerjahn, F. Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity? Nat. Rev. Rheumatol. 13, 621\u2013630 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"381_CR47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrrheum.2013.30","volume":"9","author":"GJ Silverman","year":"2013","unstructured":"Silverman, G. J., Vas, J. & Gronwall, C. Protective autoantibodies in the rheumatic diseases: lessons for therapy. Nat. Rev. Rheumatol. 9, 291\u2013300 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"381_CR48","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.3389\/fimmu.2018.03033","volume":"9","author":"KA Lloyd","year":"2018","unstructured":"Lloyd, K. A. et al. Differential ACPA binding to nuclear antigens reveals a PAD-independent pathway and a distinct subset of acetylation cross-reactive autoantibodies in rheumatoid arthritis. Front Immunol. 9, 3033 (2018).","journal-title":"Front Immunol."},{"key":"381_CR49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.40699","volume":"71","author":"J Steen","year":"2019","unstructured":"Steen, J. et al. Recognition of amino acid motifs, rather than specific proteins, by human plasma cell-derived monoclonal antibodies to posttranslationally modified proteins in rheumatoid. Arthritis Arthritis Rheumatol. 71, 196\u2013209 (2019).","journal-title":"Arthritis Arthritis Rheumatol."},{"key":"381_CR50","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2018-214950","volume":"78","author":"ASB Kampstra","year":"2019","unstructured":"Kampstra, A. S. B. et al. Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification. Ann. Rheum. Dis. 78, 908\u2013916 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"381_CR51","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar3707","volume":"14","author":"CL Liu","year":"2012","unstructured":"Liu, C. L. et al. Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies. Arthritis Res. Ther. 14, R25 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"381_CR52","first-page":"1","volume":"4","author":"RGS Chirivi","year":"2013","unstructured":"Chirivi, R. G. S., van Rosmalen, J. W. G., Jenniskens, G. J., Pruijn, G. J. & Raats, J. M. H. Citrullination: a target for disease intervention in multiple sclerosis and other inflammatory diseases? J. Clin. Cell Immunol. 4, 1\u20138 (2013).","journal-title":"J. Clin. Cell Immunol."},{"key":"381_CR53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrneph.2016.71","volume":"12","author":"S Gupta","year":"2016","unstructured":"Gupta, S. & Kaplan, M. J. The role of neutrophils and NETosis in autoimmune and renal diseases. Nat. Rev. Nephrol. 12, 402\u2013413 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"381_CR54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","volume":"23","author":"SK Jorch","year":"2017","unstructured":"Jorch, S. K. & Kubes, P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat. Med. 23, 279\u2013287 (2017).","journal-title":"Nat. Med."},{"key":"381_CR55","doi-asserted-by":"crossref","unstructured":"Albrengues, J. et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361, eaao4227\u00a0(2018).","DOI":"10.1126\/science.aao4227"},{"key":"381_CR56","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","volume":"68","author":"DJ van der Windt","year":"2018","unstructured":"van der Windt, D. J. et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology 68, 1347\u20131360 (2018).","journal-title":"Hepatology"},{"key":"381_CR57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.imlet.2016.05.015","volume":"178","author":"M van der Linden","year":"2016","unstructured":"van der Linden, M. & Meyaard, L. Fine-tuning neutrophil activation: strategies and consequences. Immunol. Lett. 178, 3\u20139 (2016).","journal-title":"Immunol. Lett."},{"key":"381_CR58","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1301059110","volume":"110","author":"K Martinod","year":"2013","unstructured":"Martinod, K. et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl Acad. Sci. USA 110, 8674\u20138679 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"381_CR59","doi-asserted-by":"crossref","unstructured":"Gollomp, K. et al. Neutrophil accumulation and NET release contribute to thrombosis in HIT. JCI Insight 3, e99445 (2018).","DOI":"10.1172\/jci.insight.99445"},{"key":"381_CR60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejphar.2018.07.005","volume":"833","author":"Y Liang","year":"2018","unstructured":"Liang, Y. et al. Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia. Eur. J. Pharm. 833, 432\u2013440 (2018).","journal-title":"Eur. J. Pharm."},{"key":"381_CR61","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.1700639","volume":"200","author":"BM Biron","year":"2018","unstructured":"Biron, B. M. et al. PAD4 deficiency leads to decreased organ dysfunction and improved survival in a dual insult model of hemorrhagic shock and sepsis. J. Immunol. 200, 1817\u20131828 (2018).","journal-title":"J. Immunol."},{"key":"381_CR62","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00435.2010","volume":"300","author":"AA Chumanevich","year":"2011","unstructured":"Chumanevich, A. A. et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G929\u2013G938 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"381_CR63","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.kint.2017.08.014","volume":"93","author":"WM Raup-Konsavage","year":"2018","unstructured":"Raup-Konsavage, W. M. et al. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia\/reperfusion-induced acute kidney injury. Kidney Int. 93, 365\u2013374 (2018).","journal-title":"Kidney Int."},{"key":"381_CR64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2013-07-514992","volume":"123","author":"AS Savchenko","year":"2014","unstructured":"Savchenko, A. S. et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia\/reperfusion injury in mice. Blood 123, 141\u2013148 (2014).","journal-title":"Blood"},{"key":"381_CR65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.20160530","volume":"214","author":"K Martinod","year":"2017","unstructured":"Martinod, K. et al. Peptidylarginine deiminase 4 promotes age-related organ fibrosis. J. Exp. Med. 214, 439\u2013458 (2017).","journal-title":"J. Exp. Med."},{"key":"381_CR66","doi-asserted-by":"crossref","DOI":"10.1038\/srep13041","volume":"5","author":"Y Seri","year":"2015","unstructured":"Seri, Y. et al. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci. Rep. 5, 13041 (2015).","journal-title":"Sci. Rep."},{"key":"381_CR67","first-page":"616","volume":"12","author":"JE Jones","year":"2009","unstructured":"Jones, J. E., Causey, C. P., Knuckley, B., Slack-Noyes, J. L. & Thompson, P. R. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. Curr. Opin. Drug Disco. Devel 12, 616\u2013627 (2009).","journal-title":"Curr. Opin. Drug Disco. Devel"},{"key":"381_CR68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature12942","volume":"507","author":"MA Christophorou","year":"2014","unstructured":"Christophorou, M. A. et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 507, 104\u2013108 (2014).","journal-title":"Nature"},{"key":"381_CR69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.1101400","volume":"306","author":"Y Wang","year":"2004","unstructured":"Wang, Y. et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306, 279\u2013283 (2004).","journal-title":"Science"},{"key":"381_CR70","volume":"8","author":"Y Zhou","year":"2018","unstructured":"Zhou, Y. et al. Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils. Sci. Rep. 8, 15228 (2018).","journal-title":"Sci. Rep."},{"key":"381_CR71","doi-asserted-by":"crossref","first-page":"eaar6689","DOI":"10.1126\/sciimmunol.aar6689","volume":"3","author":"G. Sollberger","year":"2018","unstructured":"Sollberger, G. et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci. Immunol. 3, eaar6689 (2018).","journal-title":"Sci. Immunol."},{"key":"381_CR72","first-page":"461","volume":"7","author":"MF Konig","year":"2016","unstructured":"Konig, M. F. & Andrade, F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol. 7, 461 (2016).","journal-title":"Front Immunol."},{"key":"381_CR73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.12359","volume":"179","author":"E Pieterse","year":"2015","unstructured":"Pieterse, E. et al. Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus. Clin. Exp. Immunol. 179, 68\u201374 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"381_CR74","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.33432","volume":"64","author":"N Dwivedi","year":"2012","unstructured":"Dwivedi, N. et al. Felty\u2019s syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum. 64, 982\u2013992 (2012).","journal-title":"Arthritis Rheum."},{"key":"381_CR75","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar4579","volume":"16","author":"C Sur Chowdhury","year":"2014","unstructured":"Sur Chowdhury, C. et al. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res. Ther. 16, R122 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"381_CR76","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/art.39283","volume":"67","author":"DH Sohn","year":"2015","unstructured":"Sohn, D. H. et al. Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis. Arthritis Rheumatol. 67, 2877\u20132887 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"381_CR77","doi-asserted-by":"crossref","unstructured":"Carmona-Rivera, C. et al. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Sci. Immunol. 2, eaag3358 (2017).","DOI":"10.1126\/sciimmunol.aag3358"},{"key":"381_CR78","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist, S. et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48, 2741\u20132749 (2003).","journal-title":"Arthritis Rheum."},{"key":"381_CR79","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/pin.12715","volume":"68","author":"Y Gottlieb","year":"2018","unstructured":"Gottlieb, Y. et al. Neutrophil extracellular traps in pediatric inflammatory bowel disease. Pathol. Int. 68, 517\u2013523 (2018).","journal-title":"Pathol. Int."},{"key":"381_CR80","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.4359","volume":"233","author":"A Chrysanthopoulou","year":"2014","unstructured":"Chrysanthopoulou, A. et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J. Pathol. 233, 294\u2013307 (2014).","journal-title":"J. Pathol."},{"key":"381_CR81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2353\/ajpath.2007.060352","volume":"170","author":"F Chua","year":"2007","unstructured":"Chua, F. et al. Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 170, 65\u201374 (2007).","journal-title":"Am. J. Pathol."},{"key":"381_CR82","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbrc.2018.07.069","volume":"503","author":"JE Meegan","year":"2018","unstructured":"Meegan, J. E. et al. Citrullinated histone 3 causes endothelial barrier dysfunction. Biochem Biophys. Res. Commun. 503, 1498\u20131502 (2018).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"381_CR83","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","volume":"129","author":"B McDonald","year":"2017","unstructured":"McDonald, B. et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood 129, 1357\u20131367 (2017).","journal-title":"Blood"},{"key":"381_CR84","doi-asserted-by":"crossref","unstructured":"Deng, Q. et al. Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in Mice. Frontiers Immunol. 10, (2020).","DOI":"10.3389\/fimmu.2019.02957"},{"key":"381_CR85","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-018-2109-7","volume":"22","author":"Y Maruchi","year":"2018","unstructured":"Maruchi, Y. et al. Plasma myeloperoxidase-conjugated DNA level predicts outcomes and organ dysfunction in patients with septic shock. Crit. Care. 22, 176 (2018).","journal-title":"Crit. Care."},{"key":"381_CR86","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06263-5","volume":"9","author":"E Neubert","year":"2018","unstructured":"Neubert, E. et al. Chromatin swelling drives neutrophil extracellular trap release. Nat. Commun. 9, 3767 (2018).","journal-title":"Nat. Commun."},{"key":"381_CR87","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.4049\/jimmunol.1300436","volume":"191","author":"C Farrera","year":"2013","unstructured":"Farrera, C. & Fadeel, B. Macrophage clearance of neutrophil extracellular traps is a silent process. J. Immunol. 191, 2647\u20132656 (2013).","journal-title":"J. Immunol."},{"key":"381_CR88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pathol-011811-132445","volume":"7","author":"RS Flannagan","year":"2012","unstructured":"Flannagan, R. S., Jaumouille, V. & Grinstein, S. The cell biology of phagocytosis. Annu Rev. Pathol. 7, 61\u201398 (2012).","journal-title":"Annu Rev. Pathol."},{"key":"381_CR89","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/art.1780271107","volume":"27","author":"RM Silver","year":"1984","unstructured":"Silver, R. M., Metcalf, J. F., Stanley, J. H. & LeRoy, E. C. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 27, 1254\u20131262 (1984).","journal-title":"Arthritis Rheum."},{"key":"381_CR90","unstructured":"Clark, R. A. & Nauseef, W. M. Isolation and functional analysis of neutrophils. In:\u00a0Current Protocols in Immunology. 1\u201317 (2001)."},{"key":"381_CR91","doi-asserted-by":"crossref","unstructured":"Luo, Y. & Dorf, M. E. Isolation of mouse neutrophils. In:\u00a0Current Protocols in Immunology.\u00a01\u20136 (1997).","DOI":"10.1002\/0471142735.im0320s22"},{"key":"381_CR92","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1189\/jlb.0711387","volume":"91","author":"H Parker","year":"2012","unstructured":"Parker, H., Albrett, A. M., Kettle, A. J. & Winterbourn, C. C. Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J. Leukoc. Biol. 91, 369\u2013376 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"381_CR93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-06901-w","volume":"7","author":"M van der Linden","year":"2017","unstructured":"van der Linden, M., Westerlaken, G. H. A., van der Vlist, M., van Montfrans, J. & Meyaard, L. Differential signalling and kinetics of neutrophil extracellular trap release revealed by quantitative live imaging. Sci. Rep. 7, 6529 (2017).","journal-title":"Sci. Rep."},{"key":"381_CR94","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/art.38312","volume":"66","author":"RJ Marijnissen","year":"2014","unstructured":"Marijnissen, R. J. et al. Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis. Arthritis Rheumatol. 66, 886\u2013895 (2014).","journal-title":"Arthritis Rheumatol."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0381-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0381-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0381-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T18:13:14Z","timestamp":1695924794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0381-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-0381-3","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.G.S.C. and J.M.H.R. hold patents for different tACPA molecules. R.G.S.C., H.E., and J.M.H.R. are shareholders in Citryll B.V., which is developing tACPA for the treatment of human disease. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}